GPT and autoimmune hepatitis: First-line treatment in AIH aims to improve patient symptoms, manage hepatic inflammation, accomplish biochemical remission (normalization of AST, ALT, and IgG) [122], prevent the progression of disease, and promote the regression of scarring in fibrosis and cirrhosis [1], while minimizing the risk of drug-induced complications.